Literature DB >> 7757078

Missense mutation (G480C) in the CFTR gene associated with protein mislocalization but normal chloride channel activity.

L S Smit1, T V Strong, D J Wilkinson, M Macek, M K Mansoura, D L Wood, J L Cole, G R Cutting, J A Cohn, D C Dawson.   

Abstract

We have identified a novel CFTR missense mutation associated with a protein trafficking defect in mammalian cells but normal chloride channel properties in a Xenopus oocyte assay. The mutation, a cysteine for glycine substitution at residue 480 (G480C), was detected in a pancreatic insufficient, African-American, cystic fibrosis (CF) patient. G480C was found on one additional CF chromosome and on none of 220 normal chromosomes, including 160 chromosomes from normal African-American individuals. Western blot analysis and immunofluorescence studies revealed that, in 293T cells, the encoded mutant protein was not fully glycosylated and failed to reach the plasma membrane, suggesting that the G480C protein was subject to defective intracellular processing. However, in Xenopus oocytes, a system in which mutant CFTR proteins are less likely to experience an intracellular processing/trafficking deficit, expression of G480C CFTR was associated with a chloride conductance that exhibited a sensitivity to activation by forskolin and 3-isobutyl-1-methylxanthine (IBMX) that was similar to that of wild-type CFTR. This appears to be the first identification of a CFTR mutant with a single amino acid substitution in which the sole basis for disease is mislocalization of the protein.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7757078     DOI: 10.1093/hmg/4.2.269

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  12 in total

1.  Clinical mutations in the L1 neural cell adhesion molecule affect cell-surface expression.

Authors:  H D Moulding; R L Martuza; S D Rabkin
Journal:  J Neurosci       Date:  2000-08-01       Impact factor: 6.167

2.  Human heat shock protein 105/110 kDa (Hsp105/110) regulates biogenesis and quality control of misfolded cystic fibrosis transmembrane conductance regulator at multiple levels.

Authors:  Anita Saxena; Yeshavanth K Banasavadi-Siddegowda; Yifei Fan; Sumit Bhattacharya; Gargi Roy; David R Giovannucci; Raymond A Frizzell; Xiaodong Wang
Journal:  J Biol Chem       Date:  2012-04-13       Impact factor: 5.157

3.  Transit defect of potassium-chloride Co-transporter 3 is a major pathogenic mechanism in hereditary motor and sensory neuropathy with agenesis of the corpus callosum.

Authors:  Adèle Salin-Cantegrel; Jean-Baptiste Rivière; Masoud Shekarabi; Sarah Rasheed; Sandra Dacal; Janet Laganière; Rébecca Gaudet; Daniel Rochefort; Gaëtan Lesca; Claudia Gaspar; Patrick A Dion; Jean-Yves Lapointe; Guy A Rouleau
Journal:  J Biol Chem       Date:  2011-05-31       Impact factor: 5.157

4.  Identification of common cystic fibrosis mutations in African-Americans with cystic fibrosis increases the detection rate to 75%.

Authors:  M Macek; A Mackova; A Hamosh; B C Hilman; R F Selden; G Lucotte; K J Friedman; M R Knowles; B J Rosenstein; G R Cutting
Journal:  Am J Hum Genet       Date:  1997-05       Impact factor: 11.025

Review 5.  Cystic fibrosis: a disease of altered protein folding.

Authors:  B H Qu; E Strickland; P J Thomas
Journal:  J Bioenerg Biomembr       Date:  1997-10       Impact factor: 2.945

6.  The mechanosensory structure of the hair cell requires clarin-1, a protein encoded by Usher syndrome III causative gene.

Authors:  Ruishuang Geng; Sami Melki; Daniel H-C Chen; Guilian Tian; David N Furness; Tomoko Oshima-Takago; Jakob Neef; Tobias Moser; Charles Askew; Geoff Horwitz; Jeffrey R Holt; Yoshikazu Imanishi; Kumar N Alagramam
Journal:  J Neurosci       Date:  2012-07-11       Impact factor: 6.167

7.  TRPM1 mutations are associated with the complete form of congenital stationary night blindness.

Authors:  Makoto Nakamura; Rikako Sanuki; Tetsuhiro R Yasuma; Akishi Onishi; Koji M Nishiguchi; Chieko Koike; Mikiko Kadowaki; Mineo Kondo; Yozo Miyake; Takahisa Furukawa
Journal:  Mol Vis       Date:  2010-03-12       Impact factor: 2.367

8.  Assessing the Disease-Liability of Mutations in CFTR.

Authors:  Claude Ferec; Garry R Cutting
Journal:  Cold Spring Harb Perspect Med       Date:  2012-12-01       Impact factor: 6.915

9.  Survey of cystic fibrosis transmembrane conductance regulator genotypes in primary sclerosing cholangitis.

Authors:  J M McGill; D M Williams; C M Hunt
Journal:  Dig Dis Sci       Date:  1996-03       Impact factor: 3.199

10.  Interplay between ER exit code and domain conformation in CFTR misprocessing and rescue.

Authors:  Gargi Roy; Elaine M Chalfin; Anita Saxena; Xiaodong Wang
Journal:  Mol Biol Cell       Date:  2009-12-23       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.